NU573 · Unit 6

NU573 Unit 6 chronic disease follow-up note example

AGNP I Clinical - Adolescent and Adult Focus Purdue University Global Free custom sample in 24 to 48h

Three months into urate-lowering therapy, a composite [49]-year-old delivery route supervisor has had one flare, and his serum urate has fallen from [8.9] to [6.8] mg/dL without reaching target. Those two changes, not his history, open the NU573 Unit 6 chronic disease follow-up note, and every decision in the visit is built from them.

What this page holds

What changed leads this NU573 follow-up: a composite supervisor with gout has had one flare and a urate still above six, justifying a bracketed dose increase and continued prophylaxis. Searches like "nu 573 unit 6 assignment example", "nu573 unit 6 sample" and "nu573 unit 6 example" land here.

What a finished NU573 Unit 6 chronic disease follow-up note looks like

Just over a page. The opening line, headed interval change, gives the two facts that matter: one flare in the left great toe [last month], lasting [four] days and treated with his rescue supply, and a urate of [6.8] mg/dL, down from [8.9] at baseline. Adherence, alcohol and diet follow in three short sentences. The exam notes no tophi, a quiet first metatarsophalangeal joint, and blood pressure of [134/84]. Laboratory data include an eGFR of [78] and normal liver enzymes. The assessment reads gout, improving but not at target. The plan raises [allopurinol] by a bracketed increment, continues [colchicine] prophylaxis, rechecks urate in [about a month], and reviews his [hydrochlorothiazide], which raises urate. The next visit and the result that would prompt a call sooner close the note.

How a NU573 Unit 6 example is structured

Built so a colleague could stop after the first three lines and still know what happened, the note puts interval change first and shrinks background to one sentence referring to the problem list. Each later section answers the question the interval raised. The exam looks for tophi and active synovitis because those alter the target; the labs check kidney function because it governs dosing. The assessment carries a status word, improving, and the reason for it. The plan applies the treat-to-target approach of the 2020 ACR gout guideline: urate below [6] mg/dL, dose titration at intervals, and prophylaxis for [three to six] months after therapy begins. A medication review notes that his thiazide raises urate and records the option of switching, in brackets. The follow-up line names a date and a threshold for earlier contact.

The interval first

One flare and one urate value open the note, before any history. Everything that follows responds to those two facts, which keeps the reasoning of the visit visible from the top.

Background in a sentence

His diagnosis date, first flare and baseline urate are referenced in one line pointing to the problem list. Retelling them would push the change out of view.

Target, not symptoms

A single flare during titration is expected and does not alter the plan by itself. The urate value does, because the 2020 ACR guideline sets a numeric goal, and the note acts on that goal.

Kidneys and dosing

An eGFR of [78] is recorded because renal function limits the pace of titration. The increase stays bracketed, since the dose belongs to whoever prescribes for a real patient.

A thiazide in the way

His [hydrochlorothiazide] raises urate, and the note says so, with a bracketed alternative such as [losartan] to discuss if his blood pressure regimen is revisited.

Where marks go in NU573 Unit 6

Graders check whether the note starts with change. A follow-up that opens by retelling the diagnosis, the first flare and every prior visit reads as a new-patient note and costs marks before the plan is reached. Stopping at symptoms is the next frequent problem; a note that sees no current flare and continues the same dose misses the treat-to-target principle the guideline sets. Titration decisions made without a kidney function value, or prophylaxis stopped too early, draw safety comments. A medication that raises urate is expected to be noticed when the list includes one. Ignoring alcohol, a common trigger, also costs a point. Status words without reasons, such as stable, lose a little, and so do missing recheck intervals, unbracketed doses and a guideline cited without its year.

Get a NU573 Unit 6 example written to your instructions

Send the prior visit summary when the case includes one, since a follow-up note has to build on it, along with the condition being followed and the interval your case describes. SOAP and problem-oriented formats both work. The first sample is free and arrives in 24-48h, laid out to match your rubric.

NU573 Unit 6 questions, answered

How much history belongs in a chronic follow-up note?

Very little beyond what changed. A single line referring to the diagnosis and baseline is usually enough, with the problem list carrying the rest. The note's job is to record what happened in the interval and what was decided because of it, and graders often penalize retold history that buries the interval.

What is treat-to-target in gout?

It means adjusting urate-lowering therapy until the serum urate falls below a set level, usually six milligrams per deciliter, rather than treating only when symptoms appear. The 2020 ACR guideline recommends this approach along with flare prophylaxis when therapy starts. A follow-up note shows it by reporting the level and acting on it.

Can the note use a status word like stable?

Yes, with a reason. Stable, improving or worsening followed by the finding that supports it gives the next clinician a quick picture. The word alone tells a reader little, and many rubrics mark down status labels that do not point to data from the visit itself.